Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
The study findings “have the potential to open up new avenues for therapeutic intervention in this subset of GIST tumors.”
A conversation with Kathryn Schmitz, PhD, MPH
Although the improvement in survival with immunotherapy was modest, it is noteworthy because SCLC has been such a recalcitrant disease.
Imagine, taking a simple blood draw to find out if you have cancer, and if so, the cancer’s location and molecular type.
The three studies tested Zejula, Lynparza and veliparib in women with newly diagnosed advanced ovarian cancer.
In a clinical trial, the research team is hoping to learn more about how myeloma cells resist CAR T-cell therapy.
The study’s findings “add to accumulating evidence that HPV vaccination prevents oral infection with HPV.”
“The more information we have from well-designed studies, the better we are able to counsel our patients,” said Larissa Korde, MD.
Oncolytic viruses kill cancer cells, but studies also suggest that they can boost the immune system’s ability to recognize and kill a tumor.
In the study, the 5-year overall survival rate after a diagnosis of breast cancer was 77.6% for men, compared with 86.4% for women.
Scientists emphasize using data and analyses from completed and ongoing trials to gain a better understanding of patient outcomes.
Forty-five percent of 182 phase 3 clinical trials between 1980 and 2017 influenced guideline care or new drug approvals.
The study tested the effectiveness of CEASE, a program that aims to reduce children’s exposure to secondhand smoke by helping parents quit.
A new study suggests that, for people with pancreatic cancer, the makeup of the bacteria in their tumors could predict how long they live.
The researchers found that very few women reported discussing costs with their medical team, despite their desire to do so.
“We can speculate that there’s going to be all kinds of interesting nutritional interventions that could influence cancer.”
I’d like to invite the cancer community to consider what you will do to facilitate data-sharing for the benefit of children with cancer.
An overactive immune system is the main reason that many people with both cancer and autoimmune diseases aren’t included in clinical trials.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.